The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19

MLA

Karen McCrae, et al. “The Changing Landscape of Pharmaceutical Alternatives to the Unregulated Drug Supply during COVID-19.” Harm Reduction Journal, vol. 19, no. 1, July 2022, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12954-022-00657-x.

APA

Karen McCrae, Stephanie Glegg, Marie-Éve Goyer, Bernard Le Foll, Rupi Brar, Christy Sutherland, & Nadia Fairbairn. (2022). The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19. Harm Reduction Journal, 19(1), 1–9. https://doi.org/10.1186/s12954-022-00657-x

Chicago

Karen McCrae, Stephanie Glegg, Marie-Éve Goyer, Bernard Le Foll, Rupi Brar, Christy Sutherland, and Nadia Fairbairn. 2022. “The Changing Landscape of Pharmaceutical Alternatives to the Unregulated Drug Supply during COVID-19.” Harm Reduction Journal 19 (1): 1–9. doi:10.1186/s12954-022-00657-x.